Patent · US Active

Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters

US9498485B2 · kind B2 · utility

23Cited by

242References

1Claims

0Family size

Assignee

Lipocine, Inc. · US

Inventors

Mahesh V. Patel · Salt Lake City, US
Nachiappan Chidambaram · Salt Lake City, US
Satish Kumar Nachaegari · Salt Lake City, US
Srinivasan Venkateshwaran · Salt Lake City, US
Joel Frank · Sandy, US

Key dates

Filing date	Aug 28, 2015
Grant date	Nov 22, 2016
Priority date	—
Expiry date	Aug 28, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K39/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.